At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Stephan Stilgenbauer, MD, of Ulm University, Ulm, Germany, reviews the changing chronic lymphocytic leukaemia (CLL) treatment landscape and the progress of optimising new therapeutic approaches for clinical practice.
Login to continue
Members
Create Account
Create your own personal healthcare feed, full of the latest content from across our divisions.
Register
![EMJ Oncology 10 [Supplement 6] 2022 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2022/03/EMJ-Oncology-10-Supplement-6-2022-Feature-Image-940x563.jpg)
![EMJ Oncology 10 [Supplement 5] 2022 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2022/03/EMJ-Oncology-10-Supplement-5-2022-Feature-Image-1-940x563.jpg)